Delivery Order HT940622D0001-HT940622F0007
Award Date
1/27/22
Potential Completion Date
9/30/22
Potential Value
$553K
Federal Agency
Defense Health Agency
Awardee
Gen-Probe Incorporated
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Marlborough, MA 01752, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the Defense Health Agency to Gen-Probe Incorporated, a medical diagnostics company that produces molecular diagnostic testing systems and assays. The contract is for the delivery of APTIMA SARS-CoV-2 tests to detect COVID-19, with a potential value of $745,185.00 and a completion date of March 31, 2023. The contract is part of the agency's efforts to procure necessary medical supplies related to the Coronavirus COVID-19 national interest...
This contract award to Gen-Probe Incorporated, a medical diagnostics company, is for the APTIMA SARS-COV-2 ASSAY, a product to detect COVID-19, for the Defense Health Agency. The firm-fixed-price purchase order has a potential value of $249,560.00 and a completion date of May 12, 2022. The contract does not have a set-aside designation. Gen-Probe Incorporated, through its Gen-Probe Sales & Service, Inc. division, has previously provided a variety of medical products and services to federal...
This federal contract award to Gen-Probe Incorporated, a medical diagnostics company, is for the delivery of PANTHER FUSION SARS-COV2 ASSAY PPR SOLUTION (test kits) and DNA/RNA ENZYME CARTRIDGE (reagent) kits in support of the COVID-19 response. The $1,800,000.00 firm fixed-price delivery order was issued by the Medical Command (MEDCOM) of the U.S. Department of the Army. The contract has no set-aside designation. Gen-Probe, a large specialized supplier in molecular diagnostics, has held...
The Defense Health Agency (DOD) awarded a $320,542.72 delivery order contract to Gen-Probe Incorporated Gen-Probe Sales & Service, Inc. Division for APTIMA SARS-COV-2 ASSAY, EUA, 250-TEST. The firm fixed price contract has a period of performance starting on January 20, 2022 through February 18, 2022 and will be performed in Portsmouth, Virginia. Gen-Probe Incorporated will provide its APTIMA SARS-COV-2 ASSAY test kits, which have received Emergency Use Authorization from the U.S. Food and...
This federal contract award, valued at $25,000.00, was issued by the Defense Health Agency to Gen-Probe Incorporated, a medical diagnostics company, for the procurement of PANTHER COVID-19 testing supplies. The contract is a purchase order with a firm fixed price and does not have a set-aside designation. Gen-Probe Incorporated is a key supplier of molecular diagnostic testing systems, assays, and related products and services to various federal agencies, including the Department of Defense,...
This federal contract award was made by the Defense Health Agency to Gen-Probe Incorporated, a medical diagnostics company, for the provision of COVID-19 reagents. The Firm Fixed Price Delivery Order has a ceiling value of $319,600.00 and an ultimate completion date of February 26, 2021. Gen-Probe is an experienced federal contractor, holding multiple Indefinite Delivery Contracts (IDCs) and Blanket Purchase Agreements (BPAs) with defense and civilian agencies to supply a range of molecular...
This firm fixed-price purchase order was awarded by the Defense Health Agency to Gen-Probe Incorporated, a medical diagnostics company, for the procurement of 250 APTIMA SARS-CoV-2 assay test kits, 30 APTIMA SARS-CoV-2 controls, and 76 Fusion specimen lysis tubes. The total potential value of the award is $239,790.00. The purchase order was not set aside and supports the government's Coronavirus COVID-19 response efforts. Gen-Probe Incorporated is a provider of molecular diagnostic testing...
This federal contract award is for a minimum guarantee delivery order with a firm fixed price of $456,519.00, issued by the Department of the Army Medical Command to Gen-Probe Incorporated, a medical diagnostics company. The award does not have a set-aside designation. Through this contract, Gen-Probe Incorporated will provide a variety of goods and services, including APTIMA combo assay test kits for chlamydia and gonorrhea, APTIMA HIV-1 and hepatitis C virus tests, PANTHER FUSION systems and...
This is a $158,550.00 Firm Fixed Price Delivery Order contract awarded by the Defense Health Agency (DHA) to Gen-Probe Incorporated, a medical diagnostics company. The contract is for the provision of COVID-19 assays, with an ultimate completion date of January 15, 2021. Gen-Probe is a prime contractor that has held numerous contracts with defense and civilian agencies, primarily supplying testing kits, reagents, and equipment for detecting infectious diseases. This award is not associated...
This federal contract award was issued by the Bureau of Medicine and Surgery, a component of the U.S. Department of the Navy, to Gen-Probe Incorporated, a medical diagnostics company. The $311,712.50 Firm Fixed Price Delivery Order is for APTIMA COMBO 2, 250-TEST KIT, PANTHER test kits. The contract does not have a set-aside designation. Gen-Probe is a key supplier of molecular diagnostic testing systems, assays, and related products and services to the U.S. federal government, including the...